(Circulation. 1996;94:763-774.)
© 1996 American Heart Association, Inc.
Articles |
Computer Simulation of Systemic Circulation and Clot Lysis Dynamics During Thrombolytic Therapy That Accounts for Inner Clot Transport and Reaction
the Bioengineering Laboratory, Department of Chemical Engineering, The State University of New York at Buffalo.
Correspondence to Dr Scott L. Diamond, Bioengineering Laboratory, Department of Chemical Engineering, The State University of New York, Buffalo, NY 14260. E-mail sdiamond@eng.buffalo.edu.
Background We developed a computer model to predict lysis rates of thrombi for intravenous thrombolytic regimens based on the convective/diffusive penetration of reacting and adsorbing fibrinolytic species from the circulation into the proximal face of a dissolving clot.
Methods and Results Solution of a one-compartment plasma model provided the dynamic concentrations of fibrinolytic species that served as inlet conditions for simulation of the one-dimensional spatiodynamics within a dissolving fibrin clot of defined composition. The model predicted the circulating levels of tissue plasminogen activator (TPA) and plasminogen levels found in clinical trials for various intravenous therapies. To test the model predictions under in vitro conditions, plasma clots were perfused with TPA (0.1 µmol/L) and plasminogen (1.0 µmol/L) delivered at constant permeation velocity of 0.1 or 0.2 mm/min. The model provided an accurate prediction of the measured lysis front movement. For TPA administration regimens used clinically, simulations predicted clot dissolution rates that were consistent with observed reperfusion times. For unidirectional permeation, the continual accumulation of adsorbing species at the moving lysis front due to prior rounds of solubilization and rebinding was predicted to provide for a marked concentration of TPA and plasmin and the eventual depletion of antiplasmin and macroglobulin in an advancing (
0.25 mm thick) lysis zone.
Conclusions Pressure-driven permeation greatly enhances and is a primary determinant of the overall rate of clot lysis and creates a complex local reaction environment at the plasma/clot interface. With simulation of reaction and transport, it becomes possible to quantitatively link the administration regimen, plasminogena activator properties, and thrombolytic outcome.
Key Words: fibrinolysis • hemodynamics • pharmacokinetics • plasminogen activators • thrombolysis
This article has been cited by other articles:
 |
|
 |
|
  K. Ganguly, M. S. Goel, T. Krasik, K. Bdeir, S. L. Diamond, D. B. Cines, V. R. Muzykantov, and J.-C. Murciano Fibrin Affinity of Erythrocyte-Coupled Tissue-Type Plasminogen Activators Endures Hemodynamic Forces and Enhances Fibrinolysis in Vivo J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1130 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Liu, S. Mather, Y. Huang, C. J. Garland, and X. Yao Extracellular ATP facilitates flow-induced vasodilatation in rat small mesenteric arteries Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1688 - H1695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Molina, J. Montaner, J. F. Arenillas, M. Ribo, M. Rubiera, and J. Alvarez-Sabin Differential Pattern of Tissue Plasminogen Activator-Induced Proximal Middle Cerebral Artery Recanalization Among Stroke Subtypes Stroke, February 1, 2004; 35(2): 486 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Collet, C. Lesty, G. Montalescot, and J. W. Weisel Dynamic Changes of Fibrin Architecture during Fibrin Formation and Intrinsic Fibrinolysis of Fibrin-rich Clots J. Biol. Chem., June 6, 2003; 278(24): 21331 - 21335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Komorowicz, K. Kolev, I. Lerant, and R. Machovich Flow Rate–Modulated Dissolution of Fibrin With Clot-Embedded and Circulating Proteases Circ. Res., June 1, 1998; 82(10): 1102 - 1108. [Abstract] [Full Text] [PDF]
|
|